Noyada · DIN 02543907 · 5 mg/5 mL · Oral Sol
Limited Use, Reason for Use code 707, 723 requiredMarketed · checked November 19, 2026
StatusLimited Use, Reason for Use code 707, 723 required
Write on scriptone applicable Reason for Use code, 707 or 723 (criteria below)
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 707, 723
Reason for Use code 707
For pediatric patients (less than 18 years of age) where the appropriate dose cannot be achieved using a listed solid oral dosage form of captopril.
Coverage limit:
LU Authorization Period: 1 year
Coverage limit:
Pharmacists and prescribers should be informed of and stay current with a drug product's official indications in accordance with Health Canada's approved product monograph. Some aspects of the above criteria may differ from the official indications as described in the product monograph for this drug product. The Executive Officer's funding of drug products is informed by advice from experts that consider evidence regarding the safety, clinical efficacy, and cost-effectiveness of drug products.
Reason for Use code 723
For patients unable to swallow or tolerate solid oral dosage forms of captopril.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Noyada · DIN 02543907
Manufacturer: Ethypharm Inc.; listing date 2025-10-31
Health Canada: Marketed since 2024-10-28 · brand NOYADA · ATC C09AA01 CAPTOPRIL · form Solution · route Oral · ingredients CAPTOPRIL 5 MG/5ML · company Ethypharm inc · schedule Prescription
Noyada: Formulary list price $0.60 per unit (the source does not state the unit; exact figure $0.6000). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02543907)
Source record
DIN 02543907: Noyada
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240800312; group id 316; item number 0699; lccId 00419; manufacturer id ETH
Source form: Oral Sol; strength: 5mg/5mL
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.6000; ministry $0.6000
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02543907
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=103233
Shortage status: not checked (no credentials)